BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2013
View Archived Issues
MicroRNAs hold promise for regenerating cardiac mass
Read More
Oral LM11A-31 shows promise in mouse models of spinal cord injury
Read More
[11C]-DED shows potential as a novel imaging tracer in Alzheimer's disease
Read More
CEO describes development activity at Synageva BioPharma
Read More
Roche and Siena Biotech disclose new BACE inhibitors
Read More
Novel tau suppressors prepared at reMYND NV
Read More
Tasly Pharmaceutical Group synthesizes new agents for depression
Read More
Dezima Pharma in-licenses CETP inhibitor
Read More
Olatec begins phase II trial of OLT-1177
Read More
U.S. and Korean researchers patent new fusion proteins
Read More
Synthon reports early results from its HER2 antibody-drug conjugate
Read More
Alnylam Pharmaceuticals divulges novel ribonucleic acids targeting hepcidin
Read More
Novartis receives E.U. approval for Bexsero
Read More
Omeros reports phase III safety data for OMS-302
Read More
BioDelivery Sciences completes BNX safety study
Read More
Results reported from pivotal phase III Penthrox trial
Read More
Galectin Therapeutics reports preclinical data for GR-MD-02
Read More
Ablynx development priorities detailed at J.P. Morgan Healthcare Conference
Read More
Replikins reports latest research
Read More
Emergent BioSolutions begins phase II study of BioThrax in conjunction with antibiotics
Read More
Stealth Peptides reports phase I data for oral Bendavia
Read More
Advanced Cell Technology amends protocol for phase I trials in SMD and dry AMD
Read More
Progenics acquires Molecular Insight Pharmaceuticals
Read More
Domain Therapeutics grants Prexton Therapeutics option to mGlu4 PAMs
Read More
Celsion and Zhejiang Hisun Pharmaceutical enter into agreement for ThermoDox
Read More
Encouraging results from Nymox's phase III reinjection study of NX-1207
Read More
Novartis to return NIC-002 rights to Cytos
Read More